Screener
Tango Therapeutics TNGX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's free cash flow?
- Tango Therapeutics (TNGX) reported free cash flow of -$44.36M in Q1 2026.
- How has Tango Therapeutics's free cash flow changed year-over-year?
- Tango Therapeutics's free cash flow decreased by 6.3% year-over-year, from -$41.75M to -$44.36M.
- What is the long-term trend for Tango Therapeutics's free cash flow?
- Over 4 years (2021 to 2025), Tango Therapeutics's free cash flow has grown at a 22.9% compound annual growth rate (CAGR), from -$61.36M to -$139.93M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Tango Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude